VAERS reports by lot

GSK Flu lot 5LR3F: VAERS reports

22 VAERS reports list lot 5LR3F as a GSK Flu vaccine, received between 2017-10-23 and 2018-11-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
9%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1425%
Neurological1120%
General / Systemic (non-local)1018%
Gastrointestinal814%
Allergic / Anaphylactic59%
Cardiac / Cardiovascular35%
Dermatological (non-injection-site)24%
Thrombotic / Hematological12%
Autoimmune / Immune-mediated12%
Musculoskeletal12%

Where reports came from

U.S. state of the reporter, where given (top 10).

New Mexico5
Illinois4
Georgia2
Utah2
Wisconsin1
Kansas1
Nebraska1
Texas1
California1
Maryland1

Reports by month received

2017-102
2017-115
2017-122
2018-011
2018-022
2018-038
2018-101
2018-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.